Overcome cancer cell drug resistance using natural products

Evidence-based Complementary and Alternative Medicine

Volumn 2015, Issue , 2015, Pages

  Wang, Pu ^a   Yang, Hua Li ^a   Yang, Ying Juan ^a   Wang, Lan ^a   Lee, Shao Chin ^a  

^a SHANXI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC TRIOXIDE; BAICALIN; BERBERINE; DAUNORUBICIN; DAURICINE; DIHYDROARTEMISININ; DIMETHYL ETHER; DOXORUBICIN; EMODIN; EPHEDRINE; EVODIAMINE; GINSENOSIDE RB 1; GINSENOSIDE RH 2; GLYCOSIDE; IRISQUINONE; ISORHYNCHOPHYLLINE; MATRINE; NATURAL PRODUCT; NEFERINE; ORIDONIN; OSTHOLE; OXYMATRINE; PEIMININE; QUERCETIN; RETINOIC ACID; SCHIZANDRIN; SCHIZANDROL A; TETRAMETHYLPYRAZINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VINCRISTINE;

CANCER CELL; CELL DEATH; CHINA; CHINESE MEDICINE; DETOXIFICATION; DRUG RESISTANCE; EFFUSION; HUMAN; IC50; IN VITRO STUDY; IN VIVO STUDY; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 84941687093     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2015/767136     Document Type: Review

References (174)

1. B. Stewart and C. P. Wild, World Cancer Report, IARCNonserial Publication, 2014.
2. J. L. Markman, A. Rekechenetskiy, E. Holler, and J. Y. Ljubimova, "Nanomedicine therapeutic approaches to overcome cancer drug resistance. Advanced Drug Delivery Reviews, vol. 65, no. 13-14, pp. 1866-1879, 2013.
3. D. C. Swinney and J. Anthony, "How were new medicines discovered?" Nature Reviews Drug Discovery, vol. 10, no. 7, pp. 507-519, 2011.
4. C. Basmadjian, Q. Zhao, E. Bentouhami, et al, "Cancer wars: natural products strike back. Frontiers in Chemistry, vol. 2, article 20, 2014.
5. P. A. Sotiropoulou, M. S. Christodoulou, A. Silvani, C. Herold-Mende, and D. Passarella, "Chemical approaches to targeting drug resistance in cancer stem cells. Drug Discovery Today, vol. 19, no. 10, pp. 1547-1562, 2014.
6. A. Cort and T. Ozben, "Natural product modulators to overcomemultidrug resistance in cancer, "Nutrition and Cancer, vol. 67, no. 3, pp. 411-423, 2015.
7. D.-M. Zhang, C. Shu, J.-J. Chen, et al, "BBA, a derivative of 23-hydroxybetulinic acid, potently reverses ABCB1-mediated drug resistance in vitro and in vivo, "Molecular Pharmaceutics, vol. 9, no. 11, pp. 3147-3159, 2012.
8. H.-Q. Guo, G.-N. Zhang, Y.-J. Wang, et al, Elemene, a compound derived from Rhizoma zedoariae, reverses multidrug resistance mediated by theABCB1 transporter. Oncology Reports, vol. 31, no. 2, pp. 858-866, 2014.
9. X.-C. Huang, X. Xiao, Y.-K. Zhang, et al, "Lamellarin O, a pyrrole alkaloid from an Australian marine sponge, Ianthella sp, reverses BCRP mediated drug resistance in cancer cells. Marine Drugs, vol. 12, no. 7, pp. 3818-3837, 2014.
10. Y. Zhang, Y. Zhang, Y. Wang, et al, "Esters of the marinederived triterpene sipholenol A reverse P-GP-mediated drug resistance. Marine Drugs, vol. 13, no. 4, pp. 2267-2286, 2015.
11. G. Housman, S. Byler, S. Heerboth, et al, "Drug resistance in cancer: an overview. Cancers (Basel), vol. 6, no. 3, pp. 1769-2792, 2014.
12. Q.Wu, Z. Yang, Y. Nie, Y. Shi, and D. Fan, "Multi-drugresistance in cancer chemotherapeutics: mechanisms and lab approaches. Cancer Letters, vol. 347, no. 2, pp. 159-166, 2014.
13. R. K. Vadlapatla, A. D. Vadlapudi, D. Pal, and A. K. Mitra, "Mechanisms of drug resistance in cancer chemotherapy: coordinated role and regulation of efflux transporters and metabolizing enzymes. Current Pharmaceutical Design, vol. 19, no. 40, pp. 7126-7140, 2013.
14. F. J. Sharom, "ABC multidrug transporters: structure, function and role in chemoresistance. Pharmacogenomics, vol. 9, no. 1, pp. 105-127, 2008.
15. L. A. Doyle, W. Yang, L. V. Abruzzo, et al, "A multidrug resistance transporter from human MCF-7 breast cancer cells. Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 26, pp. 15665-15670, 1998.
16. P. A. Fetsch, A. Abati, T. Litman, et al, "Localization of the ABCG2 mitoxantrone resistance-Associated protein in normal tissues. Cancer Letters, vol. 235, no. 1, pp. 84-92, 2006.
17. E. L. Niero, B. Rocha-Sales, C. Lauand, et al, "Themultiple facets of drug resistance: one history, different approaches. Journal of Experimental & Clinical Cancer Research, vol. 33, no. 1, article 37, 2014.
18. I. R. Indran, G. Tufo, S. Pervaiz, and C. Brenner, "Recent advances in apoptosis, mitochondria and drug resistance in cancer cells. Biochimica et Biophysica Acta-Bioenergetics, vol. 1807, no. 6, pp. 735-745, 2011.
19. D. S. Backos, C. C. Franklin, and P. Reigan, "The role of glutathione in brain tumor drug resistance. Biochemical Pharmacology, vol. 83, no. 8, pp. 1005-1012, 2012.
20. F. Joncourt, K. Buser, H. Altermatt, M. Bacchi, A. Oberli, and T. Cerny, "Multiple drug resistance parameter expression in ovarian cancer. Gynecologic Oncology, vol. 70, no. 2, pp. 176-182, 1998.
21. J. A. Green, L. J. Robertson, and A. H. Clark, "Glutathione S-Transferase expression in benign and malignant ovarian tumours. British Journal of Cancer, vol. 68, no. 2, pp. 235-239, 1993.
22. B. V. Jardim, M. G. Moschetta, C. Leonel, et al, "Glutathione and glutathione peroxidase expression in breast cancer: an immunohistochemical andmolecular study. Oncology Reports, vol. 30, no. 3, pp. 1119-1128, 2013.
23. P. Yu, Y. Du, X. Cheng, Q. Yu, L. Huang, and R. Dong, "Expression of multidrug resistance-Associated proteins and their relation to postoperative individualized chemotherapy in gastric cancer. World Journal of Surgical Oncology, vol. 12, article 307, 2014.
24. J. Ge, A.-X. Tian, Q.-S. Wang, et al, "The GSTP1 105Val allele increases breast cancer risk and aggressiveness but enhances response to cyclophosphamide chemotherapy in North China. PLoS ONE, vol. 8, no. 6, Article ID e67589, 2013.
25. E. J. Kap, S. Richter, A. Rudolph, et al, "Genetic variants in the glutathione S-Transferase genes and survival in colorectal cancer patients after chemotherapy and differences according to treatment with oxaliplatin. Pharmacogenetics and Genomics, vol. 24, no. 7, pp. 340-347, 2014.
26. X.H. Wang, S. J. Zhang, X. Guo, M. L. Sun, Q.P. Li, and H.Y. Liu, "Reversal effect and mechanism of osthole on the multidrugresistance of human bladder cancer cells T24/ADM. China Modern Medicine, vol. 19, pp. 7-9, 2012.
27. L. Nong, G. Wu, X. F. Dai, et al, "Mechanism of reversing MDR of human lung adenocarcinoma cell line A549/DDP by evodiamine. Chinese Clinical Oncology, vol. 15, pp. 487-492, 2010.
28. J.Hu, Y. Zhang, B. G. Ma, Y. P. Ju, Y. L. Li, and W. Cheng, "The experimental studies of celastrol on the reversal of multidrug resistance in K562/A02 cell line, "ThePractical Journal ofCancer, vol. 26, pp. 226-229, 2011.
29. R. Hu, K. Zhu, X. Y. Zhang, et al, "Embelin overcome the resistance of K562/D to daunorubicin. Journal China Medical Univrsity, vol. 39, pp. 272-275, 2010.
30. H. W. Yang, C. X. Qu, H. W. Guan, and H. W. Yang, "Arsenic trioxide reversing themultidrug resistance of gastric carcinoma cell line SGC7901/ADR to adriamycin. Cancer Research on Prevention and Treatment, vol. 33, pp. 148-149, 2006.
31. M. Liang, Y. Q. Zhou, S. J. Xiao, and Z. K. Dai, "Netferine reverses drug resistance of human ovarian cancer SKOV3/DDP cells. Shandong Medical Journal, vol. 51, pp. 39-41, 2011.
32. W. G. Wang, G. Q. Yu, G. Y. Zhang, C. Zhang, and H. Dong, "Quercetin overcomes drug resistance of K562/ADM cells. Heilongjiang Medicine and Pharmacy, vol. 34, pp. 28-29, 2011.
33. Y.-Y. Chen, J. Li, J.-D. Hu, et al, "Reversing effects of emodin on multidrug resistance in resistant HL-60/ADR cells. Journal of Experimental Hematology, vol. 21, no. 6, pp. 1413-1422, 2013.
34. L. Liang, S. Y. Liu, J. Wang, and W. Jiang, "Irisquinone overcomes drug resistance of A549/DDP cells. National Medical Journal of China, vol. 81, pp. 1392-1393, 2001.
35. M. H. Liu, M. P. Ren, R. Li, Z. Zhang, and S. H. Xiao, "Reversal effect of tetramethylpyrazine on cisplatin-resistant ovarian cancer cell line COC1/DDP. Chongqing Medicine, vol. 40, pp. 1982-1987, 2011.
36. H.-G.Qu, L. Gao, D. He, et al, "Effect of reversionof ganoderma lucidumpolysaccharides on cisplatin resistant in ovarian cancer cells and its mechanism. Journal of Jilin University Medicine Edition, vol. 37, no. 2, pp. 250-254, 2011.
37. L. G. Lu, M. D. Zeng, Y. M. Mao, et al, "Oxymatrine in the treatment of chronic hepatitis B for one year: a multicenter random double-blind placebo-controlled trial. Zhonghua Gan Zang Bing Za Zhi, vol. 12, no. 10, pp. 597-600, 2004.
38. B.-S. Shen and X.-W. Song, "Effects of oxymatrine on serum cytokines and hepatic fibrotic indexes in patients with chronic hepatitis B. Zhongguo Zhong Xi Yi Jie He Za Zhi, vol. 28, no. 1, pp. 17-19, 2008.
39. K. Liang, W. Wei, and Y.Y. Guan, "Clinical application prospects of berberine. Medical Recapitulate, vol. 18, pp. 2842-2843, 2012.
40. M. L. Duan and J. Song, "Pharmacology of ephedrine. in Proceedings of the Symposium of Chinese Annual Meeting of Anesthesia, 2008.
41. C. Fan, "The observation of the effects of disodiumnorcantharidate in the treatment of advanced primary liver cancer. Journal of Basic and Clinical Oncology, vol. 23, pp. 50-51, 2010.
42. Y. L. Wang, X. L. Bi, J. Gu, and S. Q. Gao, "Study on the mechanism of baicalin in psoriasis treatment. Chinese Journal of Dermatovenerology of Integrated Traditional and Western Medicine, vol. 2, pp. 209-211, 2003.
43. I. Hiroko, A. Sakae, and O. Yukio, "Effect of shosaikoto, a japanese and chinese traditional herbal medicinal mixture, on the mitogenic activity of lipopolysaccharide: a new pharmacological testing method. Journal of Ethnopharmacology, vol. 21, no. 1, pp. 45-53, 1987.
44. W. L. Deng, J. H. Xu, C. L. Li, Y. Sun, Y. Zhang, and Z. Z. Fan, "Reversal of multidrug resistance by Changweiqing on vincristine-resistant human colorectal cancer cell lineHCT8/V. Tumor, vol. 28, pp. 755-757, 2008.
45. J. H. Xu, Z. Z. Fan, J. Sun, et al, "Reversal of mulitdrug resistance by Changweiqing oral liquid on human oral epidermoid carcinoma cell line KB-A-1. Tumor, vol. 25, pp. 562-565, 2005.
46. X. M. Ji, B. Ouyang, C. Y. Wang, Y. Q. Zhang, and T. Jiang, "Wenxiafang, a traditional Chinese college of basic medical sciences, chemotherapeutic resistance in A549/DDP cells by down-regulating expression levels of P-gp, LRP and MRP. China Remedies & Clinics, vol. 6, pp. 885-888, 2006.
47. J. Liu, "Treatment of constipation using Changweiqing. Shanxi Journal of Traditional Chinese Medicine, vol. 29, pp. 11-12, 2013.
48. Q. Cao, Y. Sun, J. F. Shen, and Z. Z. Fan, "Clinical use of Changweiqing to control the infection of Helicobacter pylori. Chinese Journal of Digestion, vol. 20, p. 21, 2000.
49. Y. X. He, "Clinical treatment of chronic gastritis using changweiqing. Health Must-Read, vol. 12, p. 248, 2013.
50. Y. Zhang, H. Lu, X. W. Sun, Z. Z. Fan, J. Sun, and J. H. Xu, "Effects of Changweiqing in reversing oxaliplatin resistant HCT116/L-OHP and influence on Pt-DNA adduct. Chinese Traditional Patent Medicine, vol. 34, pp. 1843-1848, 2012.
51. F. B. Feng, J. Zhuang, H. E. Han, Q. L. Lv, and C. G. Sun, "Research on Chinese herbal compound of reducing phlegm and resolvingmasses on reversal ofmultidrug resistance mechanism of MCF-7/ADM transplantation tumor in nude mice. Acta Academiae MedicinaeWeifang, vol. 36, pp. 211-213, 2014.
52. G. Liang, X. Z. Lin, L. Li, M. Zhou, and A. Z. Tang, "MDRreversing effect of (-)epigallocatechin-3-gallate on humanMDR cell lines KBV200. Cancer Research on Prevention and Treatment, vol. 34, pp. 4-7, 2007.
53. L. Wang, P. K. Wei, Z. F. Qin, et al, "Experimental study on puerarin injection reverse multidrug resistance of nude mice of human gastric carcinoma constructed using orthotopic transplantation. Journal of Chengdu University of Traditional Chinese Medicine, vol. 28, pp. 42-46, 2005.
54. W.D. Lu, Z.X. Fu, Y. Qin, L. Li, and C. Yang, "Curcumin reverses multidrug resistance inHCT-8/VCRnude mice xenograft. Acta Academiae Medicinae Militaris Tertiae, vol. 33, pp. 376-380, 2011.
55. X. Wang, Establishment ofHcamultidrug resistancemousemodel and study of cepharanthine hydrochloride on overcoming its drug resistance [M.S. thesis], Zhenzhou University, 2008.
56. F. Sun, N. Wang, G. Li, X. Wang, X. Li, and G. Yin, "The effect of matrine on the expression of P170 LRP and TOPOII of obtained multi-drug resistance of mouse S180's tumour cell. Journal of Chinese Medicinal Materials, vol. 27, no. 11, pp. 838-840, 2004.
57. F.-J. Sun, X.-C. Nie, G.-H. Li, and G.-P. Yin, "The study of tetrandrine on reversion of P170 and apoptosis of obtained multi-drug resistante of mice S180's tumour cell. China Journal of Chinese Materia Medica, vol. 30, no. 4, pp. 280-283, 2005.
58. K.W. Hu, X. Y. Chen, M. H. Zuo, et al, "Fritillaria thunbergii powder overcomes drug resistance of acute leukemia patients. China Journal of Traditional Chinese Medicine and Pharmacy, vol. 19, pp. 68-70, 2004.
59. W. Li, K. W. Hu, W. Su, Y. L. Sun, X. Y. Chen, and B. Liang, "Clinical trial of Fritillaria thunbergii Bulb powder for reversing multidrug resistance in the patients with acute leukemia. Journal of BeijingUniversity of Traditional ChineseMedicine, vol. 27, pp. 63-65, 2004.
60. Y. C. Zhao, X. Y. Chen, Y. M. Xu, and Z. Jia, "Principal clinical study on ligustrazine injection to counteract the multi-drug resistance of acute leukemia. Chinese Journal of Information on Traditional Chinese Medicine, vol. 10, pp. 10-11, 2003.
61. L. Q. Zhu, S. Xu, L. Luo, Z. Li, L. L. Qiu, and C. F. Xu, "Reversal of multidrug resistance in drug-resistance human choriocarcinoma cell line JAR/VP16 by effective component of Verbena officinalis L. Acta Universitatis Medicinalis Nanjing, vol. 27, pp. 419-423, 2007.
62. J. H. Li, G. Q. Qin, and P. M. Yang, "Reversal of multidrug resistance in human K562/ADMcell line by dauricine. Journal of Dalian Medical University, vol. 24, pp. 94-96, 2002.
63. W. Q. Chen, H. W. Qi, C. G. Wu, Z. K. Li, C.W. Bai, and Y. G. Liu, "Inhibition of growth on the human lung adenocarcinoma cell line A549 and A549/CDDP in vitro by dihydroartemisinin in combination with cisplatin. Journal ofModernOncology, vol. 14, pp. 284-286, 2006.
64. H. Zhang, H.-Q. Wang, H.-L. Zhang, D. Kong, and X.-Z. Wu, "Ginsenoside Rh2 reverses p-glycoprotein-mediated multidrug resistance ofMCF-7/ADMcells. Tumor, vol. 27, no. 5, pp. 365-369, 2007.
65. Y. L. Zhou, Z. W. Zhou, and R. Zeng, "Reversal effect of isorhynchophylline on cisplatin resistance of line A549/DDP human lung adenocarcinoma cells. Central South Pharmacy, vol. 6, pp. 267-269, 2008.
66. Y. L. Zhou, M. X. Tang, and S. K. Liu, "Reversal effect of isorhynchophylline on lung adenocarcinoma drug-resistant cell line A549/DDP. Chinese Journal of New Drugs, vol. 18, p. 1338, 2009.
67. Z. W. Zhou and Y. L. Zhou, "Effect of isorhynchophylline liposomes on cisplatin resistance of human lung adenocarcinoma cell line A549/DDP. Journal of Traditional Chinese Medicine University of Hunan, vol. 28, pp. 29-31, 2008.
68. J. H. Li and P. M. Yang, "Study on ligustrazine in reversing multidrug resistance of K562/ADM cell. Modern Journal of Integrated Traditional Chinese andWesternMedicine, vol. 10, pp. 1405-1407, 2001.
69. Q. Fan, G. J. Fan, J. Y. Zhao, and P. M. Yang, "Study on effect reversing MDR of ligustrazine liposomes on human erythroleukemia-cell-line K562/ADM. China Pharmacist, vol. 7, pp. 753-755, 2004.
70. Y. F. Ding, X. Xie, J. Y. Zhao, and P. M. Yang, "Reversal of adriamycin resistance by matrine in leukemia multidrug resistance cell line K562/ADM. Journal of Dalian Medical University, vol. 26, pp. 256-259, 2004.
71. P. Zhang, Z. Y. Gu, Y. H. Sun, and Y. Z. Nie, "Reversal effect of peiminine on gastric cancer multidrug resistance. Journal of Xinjiang Medical University, vol. 35, pp. 452-456, 2012.
72. L. Li and Q. X. Fan, "Reversal effect of schisandrin A onMRP1-mediated multidrug resistance. Journal of Chinese Practical Diagnosis and Therapy, vol. 23, pp. 857-859, 2009.
73. D. Pang, Study of the reversal effect of tanshinone II. A on multidrug-resistance of breast cancer [M.S. thesis], Sichuan University, 2007.
74. Y.Q. Shi, M. Deng, L. X. Zhu, and R. X. Yu, "Primary study on reversal effect of radix acanthoparacis senticosi on multidrug resistance of K562/ADR cells in vitro. Chinese Journal of Traditional Medical Science and Technology, vol. 11, pp. 93-95, 2004.
75. Y. Han, L. M. Bu, X. Ji, C. Y. Liu, and Z. H. Wang, "Modulation of multidrug resistance by andrographolid in a HCT-8/5-FU multidrug-resistant colorectal cancer cell line. Chinese Journal of Digestive Diseases, vol. 6, no. 2, pp. 82-86, 2005.
76. B. Jiang and Q. L. Liu, "The reverse role of the activity of Banlangen to human multidrug-resistant hepatocarxinoma cell. Journal of Jining Medical College, vol. 27, pp. 11-13, 2004.
77. H. Liu, "Reversal effect of Angelicae sinensis onDOX resistance gastric cancer cell line SGC-7901/ADR. World Health Digest, vol. 6, pp. 31-33, 2009.
78. B. Liao, R. Y. Ge, C. B. Xu, et al, "Reversal effect of Chinese medicine compound FFJZ on multidrug resistance of leukemia K562/VCR cell line. Journal of Fujian University of Traditional Chinese Medicine, vol. 21, pp. 9-12, 2011.
79. H. J. Xing, H. Y. Cui, and J. H. Zhao, "Apigenin reverses drug resistance of HCT8/5-FU cells by down-regulation of MDR1. Chinese Journal Gerontology, vol. 34, pp. 3709-3712, 2014.
80. J. Cheng, J. P. Feng, Y. P. Wang, M. Li, and Q. Z. Kong, "Effect of arsenic trioxide on MRP expression in A549/R cell line of human lung cancer. Herald of Medicine, vol. 26, pp. 457-460, 2007.
81. H. Li, M.-M. Xiong, X.-L. Meng, and X.-P. Geng, "Reversing effect of arsenic trioxide on multidrug resistance of human hepatocellular carcinoma HepG2/ADM cells. World Chinese Journal of Digestology, vol. 14, no. 27, pp. 2691-2694, 2006.
82. H. W. Yang, C. X. Qu, and H. W. Guan, "Arsenic trioxide reversing themultidrug resistance of gastric carcinoma cell line SGC7901/ADR to adriamycin. Cancer Research on Prevention and Treatment, vol. 33, pp. 148-149, 2006.
83. H. P. Yu, L. Cui, and Y. J. Pan, "Reversal of drug resistance in multidrug-resistant MCF-7/ADR cells of breast cancer by artemisinin. ActaMedicinae Universitatis Scientiae et Technologiae Huazhong, vol. 40, pp. 91-94, 2011.
84. X. J. Fu, H. Yao, L. E. Lin, et al, "Study on artesunate in reversing MDR of multiple myeloma cell lines. Acta Universitatis Medicinalis Anhui, vol. 48, pp. 1075-1078, 2013.
85. L. J. Yang, T. Zhao, Q.X. Bai, and H. J. Dong, "Reversal effect and machenism induced by baicalin on leukemia cell line. Shanxi Medical Journal, vol. 41, pp. 775-779, 2012.
86. S. H. Wang, "The multidrug-resistant mechanism study of reverse effect of Baicalin for hepatocellular carcinoma cell line (Bel 7402/ADM). Chinese Journal ofModern Drug Application, vol. 6, pp. 10-11, 2012.
87. Y. Q. Han, Y. J. Shi, J. Y. Yuan, Y. Zhu, and S. L. Wu, "The study of reversal resistance effect and its mechanism of berbamine in MCF7/ADR cells. Acta Anatomica Sinica, vol. 35, pp. 161-164, 2004.
88. Y.Wu, Y. Zeng, and S. Y. Liang, "The exploratory research on the berberine reverse theHCT-8/VCRmultidrug resistance and its relationship with P-gp functional variance. Guide of China Medicine, vol. 8, pp. 18-20, 2010.
89. X. L. Yu, H. Li, X. L. Chen, X. X. Li, R. Wang, and F. Gao, "Study on reversing mechanism of multidrug resistance of K562/A02 cell line by carnosic acid. Chinese Journal of Hematology, vol. 31, pp. 381-384, 2010.
90. Z. Cao, L.-J. Wang, M.-H. Wu, Y. Qiao, Y.-J. Sun, and J. Guo, "Mechanism governing reversal of multidrug resistance in human breast carcinoma cells by chelerythrine. Acta Academiae Medicinae Sinicae, vol. 33, no. 1, pp. 45-50, 2011.
91. Y. Qin, Z. X. Fu, W. D. Lu, L. Li, and W. X. Tang, "Experimental study of multidrug-resistance reversing of curcumin on human colon carcinoma HCT-8/VCR cells. Chinese Journal of Biochemical Pharmaceutics, vol. 32, pp. 173-179, 2011.
92. H. Y. Chang, F. C. Oan, X. Y. Jiao, et al, "The study on reversing mechanism of multidrug resistance of K562/A02 cell line by curcumin and erythromycin. Chinese Journal of Hematology, vol. 27, pp. 254-257, 2006.
93. L. Wang, P. K. Wei, Z. F. Qin, et al, "Experimental study on reversion effect of elemene on multidrug resistance of human gastric cancer cell line. Journal of Chengdu University of Traditional Chinese Medicine, vol. 28, pp. 51-53, 2005.
94. C.M. Chen, W. Z. Yang, C.H. Wang, X. Y. Yang, and S. S. Shi, "Reverse of drug resistance against ADMin U251/ADMcells by elemene. Chinese Journal of Experimental Surgery, vol. 23, pp. 601-603, 2006.
95. C. C. Yao, Y. R. Tu, J. Jiang, et al, "Elemene reversed the multidurg resistance of A549/DDP lung cancer cells via mitochondrial apoptosis pathway. Journal of Modern Oncology, vol. 22, pp. 1276-1281, 2014.
96. J. Q. Mao, Y. Zhang, J. Gu, X. Zhang, and L. Ma, "Reversal of multidrug resistance in K562/A02 cell by ephedrine. Chinese Journal of Hospital Pharmacy, vol. 27, pp. 156-159, 2007.
97. F. Zhao, M. H. Zhang, X. L. Chen, et al, "MDR-reversing effect of EGCG by decreasing expression of p-glycoprotein on human leukemic cell line. Journal of Oncology, vol. 10, pp. 389-392, 2004.
98. Y. H. Li, "Experimental study on EGCGreversing themultidrug resistance of esophageal cancer cell line Eca109/DDP. Guide of Chinese Medicine, vol. 11, pp. 414-415, 2013.
99. P. Yang, J. Cao, M. H. Tan, et al, "Reversal of resistance to Oxaliplatin in human colon cancer by gambogic acid. Chinese Archives of General Surgery (Electronic Edition), vol. 7, pp. 273-277, 2013.
100. Y. Li, Z. Z. Wang, and T. F. Yu, "In vitro study on the reversal of multidrug resistance (MDR) in HL60/VCR cell line with ginsenoside-Rb1. Journal of Radioimmunology, vol. 18, pp. 362-365, 2005.
101. H. L. Wen, X. M. Li, W. T. Zeng, and K. L. Zhu, "Effect of ginsenoside on reversal of multidrug resistance of hepatocellular carcinoma cells bel-7402: an experimental study. Chinese Journal of Biomedical Engineering, vol. 18, pp. 191-194, 2012.
102. W. Zhang, S. Y. Liu, J. Wang, et al, "Reversal effect of ginsenoside Rg3 on cisplatin-resistant human lung adenocarcinoma cell line (A549DDP) and itsmechanisms. Chinese Journal of Respiratory and Critical Care Medicine, vol. 1, pp. 100-103, 2002.
103. L. Dong, X. Q. Tang, J. G. Cao, S. H. Shi, Y. Z. Zhuang, and J. G. Zhou, "Reversal effect of neferine on resistance to vincristine in humanmultidrug-resistant gastric carcinoma cell line SGC7901/VCR. Chinese Journal of Pathophysiology, vol. 20, pp. 1407-1410, 2004.
104. X.-B. Xiao, Z.-X. Xie, J. Chen, Q. Qin, and Y. Zhu, "Effect of neferine on the chemotherapic sensitivity of STI 571 to K562/A02 cells. Journal of Central South University (Medical Sciences), vol. 30, no. 5, pp. 558-561, 2005.
105. C. H. Huang and P. G. Cai, "The study of neferine onmultidrug resistance reversing of the human breast cancer cell line MCF-7/Adr. Cancer Research on Prevention and Treatment, vol. 34, pp. 351-353, 2007.
106. J. J. Guo, X. L. Pan, C.W. Feng, and J.H. Zhou, "Studyonreversal effects of Oridonin on multidrug resistant cell line K562/A02. Shanghai Medical Journal, vol. 25, pp. 43-45, 2002.
107. J. Y. Lv and Y. Zhao, "Oxymatrine overcomes the drug resistance ofMCF-7/ADMcells. ChinaModern Doctor, vol. 48, pp. 86-87, 2010.
108. X. Y. Tang and Y. X. Tang, "Efficiency and mechanisms of peimine reversingmulti-drug resistance of A549/DDP cell line. Shandong Medical Journal, vol. 52, pp. 4-6, 2012.
109. Y. Cai, T. G. Cai, F. D. Tang, R. H. Zhang, L. He, and L. Q. Xu, "Reversal effect of multidrug resistance on K562/ADM cell by Psoralen. Chinese Journal of Clinical Oncology, vol. 31, pp. 146-148, 2004.
110. F. B. Du, M. H. Bao, and X.D. Mei, "Research on the reversal of multidrug resistance of human carcinoma cell line KB-MRP by quercetin. Chinese Clinical Oncology, vol. 12, pp. 659-662, 2007.
111. X. H. Qiao, H. F. Tang, L. Song, S. Y. Long, D. X. Zhou, and S. C. Liu, "Quercetin reverses drug resistance of leukemia cells. Chinese Journal of Clinical Pharmacology andTherapeutics, vol. 8, pp. 302-303, 2003.
112. S. X. Chen, Y. Y. Jiang, and Z. H. Fei, "Reversal effect of sodium norcantharidate on human lung adenocarcinoma cell line A549/DDP in vitro. Chinese Journal of Geriatrics, vol. 29, pp. 486-488, 2010.
113. X. L. Zhao and G. C. Xu, "A study of the reverse effect of tetramethylpyrazine on the resistant cell strain A2780/ADM of human ovarian carcinoma. The Journal of Medical Research, vol. 38, pp. 78-81, 2009.
114. J. L. Liu, J. Jiang, M. Y. Zhang, Y. Wang, Y. R. Liu, and Y. Wang, "Studies of TMP on restraining proliferation and reversing multidrug resistance in human lung adenocarcinoma cell line. Practical Oncology Journal, vol. 27, pp. 303-307, 2013.
115. H.-Y. Ma, J.-Y. Zhao, W. Jin, and L. Kong, "Effect of tetramethylpyrazine on reversing multidrug resistance of K562/MDR cells with gene transfer. Journal of Jilin University (Medicine Edition), vol. 35, no. 4, pp. 599-603, 2009.
116. Y. Sun, K. Q. He, and M. J. Gong, "Reversal effect of tetredrine (TTD) on human hepatocellular carcinoma (HCC) multidrugresistant cell line (Hep-3B/ADM). China Medicine, vol. 3, pp. 790-791, 2008.
117. L. F. Yu, Y. L. Wu, and Y. P. Zhang, "Reversal of drug resistance in the vincristine-resistant human gastric cancer cell lines MKN28/VCR by emulsion of seminal oil of Brucea javanica. World Chinese Journal of Digestology, vol. 9, no. 4, pp. 376-378, 2001.
118. C. L. Ji, Y. Y. Xie, and D. X. Sun, "Jave Brucea fruit extract overcomes drug resistance of K562/ADM cells. Zhejiang Journal of Traditional Chinese Medicine, vol. 45, pp. 458-459, 2010.
119. C. Zhang, D. M. Wan, and W. J. Cao, "Reversal effect of cinobufacini on multidrug resistance of Raji/ADR cells and its mechanisms. Journal of Experimental Hematology, vol. 22, pp. 1306-1310, 2014.
120. G. Y. Zhou, L. Li, F. Yu, Y. L. Sun, and C. Ma, "Reversal of grape seed polyphenol on multidrug resistance of MCF 7/ADR in vitro and in vivo. Journal of Shandong University (Health Sciences), vol. 42, pp. 640-642, 2004.
121. F. F. Yang, Z. M. Wang, and X. L. Wu, "Study on reversal of mutidrug resistance of GBC-SD cell lines by grape seed polyphenols. Chinese Journal of General Surgery, vol. 15, pp. 202-205, 2006.
122. L. P. Wang, B. Z. Wang, H. Y. Si, C. Zhao, and Z. X. Sui, "Effects of hyaluronate oligomers on drug resistant reverse and apoptosis enhancement in MCF-7/ADM cell line. Bulletin of Chinese Cancer, vol. 15, pp. 617-619, 2006.
123. R. Li, S. Xie, L. Zhang, and X. M. Wang, "Primary study on the mechanism of reversal drug-resistance of human breast cancer cell line MCF-7 by Huaier Granule. China Practical Medical, vol. 4, pp. 1-2, 2009.
124. Z. Yu, T. Wu, and Y. Zhang, "The reversal effects of trametes robiniophila murr. on multidrug resistance in resistant human hepatocellular carcinoma cell line BEL-7402/5-Fu. Journal of Chinese Oncology, vol. 19, pp. 443-447, 2013.
125. N. Liu, X. P. Gen, L. X. Zhu, et al, "MDR-reversing effect of extractumTrametes robiniophilaMurr on human hepatocellular carcinomaHepG2/ADMin vitro. Chinese Journal of Hepatobiliary Surgery, vol. 13, pp. 385-388, 2007.
126. Y. Q. Shi and T. D. Tian, "Panax notoginseng extract ovrxomes drug resistance of K562/VCR cells. Chinese Journal of TraditionalMedical Science and Technology, vol. 12, pp. 292-294, 2005.
127. L. L. Liu, Y. E. Liu, and G. T. Fang, "Reversal effect of panaxnotoginseng saponins on multidrug resistance breast cancer cell MCF/ADM. Lishizhen Medicine and Materia Medica Research, vol. 19, pp. 954-956, 2008.
128. X. Q. Peng, W. Feng, and W. H. Zhang, "Reversal of multirug resistance in K562/A02 cell by alcoholic extract of pinellia ternate. Chinese Journal of Experimental Traditional Medical Formulae, vol. 18, pp. 157-160, 2012.
129. Y. H. Wang, J.Y. Zhao, C. H. Ge, and P.M. Yang, "Reversal effect and mechanism of realgar on multidrug resistance in breast tumor cells MCF-7/ADM. Progress of Anatomical Sciences, vol. 9, pp. 135-138, 2003.
130. Q. M. Li, B. E. Dan, and J. Zhang, "Reversing effect of thallus laminariae PE on drug resistance in B-MD-C1 (ADR+/+) Cell Line. Carcinogenesis, Teratogenesis & Mutagenesis, vol. 19, pp. 219-222, 2007.
131. C.M. Yang, X. B. Cui, Q. Luo, L. Sun, H. Liu, and L. X. Zhang, "Curcumin reverses cancer cell drug resistance is mediated by caspase-3. The Journal of Practical Medicine, vol. 28, pp. 355-357, 2012.
132. Y. X. Chi, Artesunate reversing drug resistance and weakening anti-Apoptosis mediated Bcl-2 in gastric cancer cells SGC7901/mdr1 [M.S. thesis], Xinxiang Medical University, Xinxiang, China, 2014.
133. C. C. Yao, Y. R. Tu, H. X. Du, et al, "The effect of elemene on reversal multidurg resistance and the expression of Pglycoprotein in A549/DDP. Journal of Modern Oncology, vol. 21, pp. 2670-2673, 2013.
134. H. L. Ma, X. J. Zhou, X. Z. Zhang, and T. Wang, "Study of -elemene on induction of apoptosis and reverses on tamoxifen drug-resist-Ance in human breast cancer cells LCC-2. Journal of Modern Oncology, vol. 22, pp. 2024-2028, 2014.
135. J. Hu, W. Jin, and P.-M. Yang, "Reversal of resistance to adriamycin in human breast cancer cell line MCF-7/ADM by -elemene. Chinese Journal of Oncology, vol. 26, no. 5, pp. 268-270, 2004.
136. X. N. Ouyang, W. Z. Fang, D. S. Wu, S. Q. Lin, J. Chen, and Z. Y. Yu, "The mechanism of rheum emodin reversed resistance of EGFR-TKI in NSCLC. Chinese Clinical Oncology, vol. 19, pp. 967-971, 2014.
137. F. Zhao, M. H. Zhang, L. Z. Li, C. L. Zhao, and L. Q. Wang, "Research on reversal effect of multidrug resistance in human leukemic cell line by EGCG and its mechanisms. Journal of Clinical Hematology, vol. 18, pp. 33-36, 2005.
138. S. Hu, Research on the efficiency and mechanisms of gensenoside Rh2 reversing the resistance of lung adenocarcinoma cells to cisplatin [Ph.D. thesis], Zhongnan University, Wuhan, China, 2004.
139. S. H. Shi and H. Zhang, "Reversal of multidrug resistance by neferine in human gastric carcinoma cell line SGC7901/VCR and its mechanism. The Practical Journal of Cancer, vol. 27, pp. 334-336, 2012.
140. Y. Liu, K. T. Yao, and G.H. Xiao, "Establishment of the gefitinibresistant A549/GR cell line of human lung adenocarcinoma and investigation of the mechanism of parthenolide in reversing drug resistance. Chongqing Medical Journal, vol. 41, pp. 3689-3694, 2012.
141. Q. Ma, F.-X. Zhang, Z.-C. Lv, J.-Y. Chen, and S.-Z. Kang, "Phenylpropanoid glycoside reverse multidrug resistance of colon carcinoma LoVo/Adr cells through induction of apoptosis. World Chinese Journal of Digestology, vol. 17, no. 23, pp. 2357-2361, 2009.
142. G. M. Sun, X. H. Li, and B. Z. Wang, "Retinoid acid overcomes drug resistance ofMCH7/TAM. ShandongMedical Journal, vol. 50, pp. 107-108, 2010.
143. Y. Q. Huang, Research on reversal of anti-Apoptotic action by tetrandrine on adriamycin-resistant human bladder carcinoma cell line BIU-87/ADM and its possible mechanisms [M.S. thesis], Fujian Medical University, 2011.
144. J. Hu, J.-Y. Zhao, and P.-M. Yang, "Studies of realgar on induction of apoptosis and reversal of drug resistance in human breast tumor cellsMCF-7/ADM. Acta Anatomica Sinica, vol. 37, no. 6, pp. 665-668, 2006.
145. Y.-Q. Han, J.-Y. Yuan, Y.-J. Shi, Y. Zhu, and S.-L. Wu, "Reversal effect of berbamine on multidrug resistance of K562/A02 cells and its mechanism. Journal of Experimental Hematology, vol. 11, no. 6, pp. 604-608, 2003.
146. X. K. Yu, X. L. Chen, and M. Hou, "Carnosic acid overcomes drug resistance of K562/A02 cells. Chinese Journal of Practical Internal Medicine, vol. 27, supplement 1, p. 66, 2007.
147. S. Jin, S. E. Chen, M. Zhang, et al, "Reversion of MDR of HL60/ADR and MCF-7/ADR with curcumin in vitro. Chongqing Medical Journal, vol. 39, pp. 21-23, 2010.
148. Y. Y. Chen, J. Li, J. D. Hu, et al, "Reversing effects of emodin on multidrug resistance in resistant HL-60/ADR cells. Journal of Experimental Hematology, vol. 2, pp. 1413-1422, 2013.
149. F. Xue, Z.-Y.Cheng, W.-T. Liang, et al, "Resistance reverse effects of honokiol on multidrug resistance of U937/ADR cell line. Journal of Shanghai Jiaotong University, vol. 29, no. 9, pp. 1035-1039, 2009.
150. S.Xu, L. Luo, L.-Q.Zhu, et al, "Reversal effect of 4-methyletherscutellarein onmultidrug resistance of human choriocarcinoma JAR/VP16 cell line. Progress in Biochemistry and Biophysics, vol. 33, no. 11, pp. 1061-1073, 2006.
151. Y. B. Wang, Z. T. Lu, Q. G. Zhang, X. J. Gao, L. G. Zhang, and H. J. Liu, "Effect of quercetin onmultidrug resistance reversal of lung adenocarcinoma cell line A549/DDP. Journal of Binzhou Medical University, vol. 36, pp. 86-89, 2013.
152. Y.-Q. Han, L.-J. Cao, H.-J. Hao, and Y.-J. Shi, "Effects of quercetin on multidrug resistance and expression of related genes in human erythroleukemic K562/a cells. Journal of Experimental Hematology, vol. 19, no. 4, pp. 884-889, 2011.
153. Y. Wei, H. Y. Zhang, and G. Liang, "The reverse effect of quercetin on multidrug resistance of human hepatocellular carcinoma. Tianjing Medical Journal, vol. 40, pp. 1022-1025, 2012.
154. Q. P. Li and Y. N. Gai, "Schisandrin B reverses multidrug resistance due toMDR1-mediated human osteosarcoma cell line U-2 OS/ADR. Anhui Medical and Pharmaceutical Journal, vol. 18, pp. 1642-1645, 2014.
155. X. Q. Qin, Y. G. Liang, H. Z. Gao, et al, "Reversing mechanism of schizandrin A on multi-drug resistance of K562/ADR, HL60/ADR, MCF-7/ADR cell lines. Chinese Pharmacological Bulletin, vol. 27, pp. 329-333, 2011.
156. J. Cui, J. Ding, Y.-P. Wu, F.-Q. Liu, X.-C. Liu, and Y. Wang, "Reversal effect of sodium selenite on multidrug resistance in K562/ADR cell line and its mechanisms. Journal of Experimental Hematology, vol. 15, no. 4, pp. 756-761, 2007.
157. Y. S. Li, J. Y. Liu, and Y. Q. Huang, "Reversing mechanism of multidrug resistance of human bladder carcinoma drugresistant cell line BIU-87/ADMby tetrandrine. Chinese Journal of Experimental Surgery, vol. 28, pp. 1526-1529, 2011.
158. X.-D. Gai, C.-Q. Zeng, and M. Hong, "Effect of bupleurun Chinese DC(BCDC) on the MDR reversal of hepatocellular carcinoma and relatedmechanism. Chemical Journal of Chinese Universities, vol. 26, no. 8, pp. 1446-1450, 2005.
159. F. H. Yang, Z.M. Wang, and X. L. Wu, "Grape seed polyphenols reverses multidrug resistance of GBC-SD cell lines. Chinese Journal of Current Advances in General Surgery, vol. 8, pp. 355-357, 2005.
160. H. F. Shi, H. F. Zhang, Q. Zhao, W. X. Zhao, and J. Dan, "Tea polyphenol overcomes drug resistance of HL60/VCR cells. Chinese Journal of Gerontology, vol. 31, pp. 258-261, 2011.
161. Y. T. Shi, H. Jing, Y. Wang, J. L. Yi, and C. Y. Liu, "Rat serum containing of Buzhong yiqi decoction reverse chemotherapeutic resistance in A549/DDP cells by down-regulating expression levels of mTOR. Chinese Journal of Experimental Traditional Medical Formulae, vol. 19, pp. 215-218, 2013.
162. W. K. Ma, Y. M. He, X. M. Yao, Y. Huang, Y. Wang, and Y. J. Li, "Reverse effect of serum containing Jiedu huayu recipe on multidrug resistance of leukemia HL60/Adr cells. Traditional Chinese Drug Research & Clinical Pharmacology, vol. 22, pp. 524-527, 2011.
163. J. Li and P. P. Liu, "The study about Herba Scutellariae Barbatae reverse the drug resistance of leukemia cell line K562/A02. Guiding Journal of Traditional Chinese Medicine and Pharmacology, vol. 18, pp. 88-89, 2012.
164. X. L. Zhang, T. Huang, X. F. Yang, L. Huang, and Y. Li, "Experimental studies on reversion effects of shehuang xiaoliu decoction on multidrug resistance of human hepatoma cells. Chinese Journal of Traditional Medical Science and Technology, vol. 21, pp. 25-27, 2014.
165. S. F. Zhou, J. Chen, and M. Wang, "Reverse effect of zedoary turmeric oil serum on multidrug-resistant of stomach cancer cell line SGC7901/CDDP. Traditional Chinese Drug Research & Clinical Pharmacology, vol. 23, pp. 508-511, 2012.
166. C. Jiang and X. G. Yang, "Study on ligustrazine combined with chemotherapy in patients with relapsed or refractory non-Hodgkin's lymphoma. Journal of InternationalOncology, vol. 37, pp. 397-400, 2010.
167. X. C. Wang, "Multidrug resistance reversal effect of breast cancer by wuweizi dranule combined with CAF chemotherapy. Chinese Journal of Experimental Traditional Medical Formulae, vol. 20, pp. 241-243, 2014.
168. J. H. Xu, Z. Z. Fan, J. Sun, et al, "Effects of 'Chang Wei Qing' in treating advanced gastrointestinal cancer and its effects on peripheral blood MDR1 mRNA. Shanghai Journal of Traditional Chinese Medicine, vol. 41, pp. 40-42, 2007.
169. H. L. Chen, X. L. Yang, and P. J. Yang, "Treatment of gastric cancer with Didang formula. China Health Industry, vol. 8, pp. 59-60, 2011.
170. Y. X. Zhang, C. H. Li, W. G. Song, and L. Jiang, "Treatment of liver cancer using Xiaochaihu formula. Seek Medical and Ask the Medicine, vol. 11, pp. 486-487, 2013.
171. P. Shu and S. L. Liu, "Clinical observation on reversal effects of multi-drug resistance gene and lung resistance protein in gastric cancer treated by shenqi jiangwei decoction. Hunan Journal of Traditional Chinese Medicine, vol. 24, pp. 1-2, 2008
172. C. Y. Huang, J. Q. Chen, Y. Shen, H. H. Xie, and X.Y. Nie, "Study on the effect of Pingxiao capsule on multidrug resistant gene P-gp, TOPOII and GST- for breast cancer. Lingnan Modern Clinics in Surgery, vol. 11, pp. 38-40, 2011.
173. Q. J. Chen, R. Zhang, H. L. Situ, et al, "Effects of Fukangling capsule on multidrug resistant geneprotein p170 and GST- of breast cancer. China Pharmacy, vol. 19, pp. 1650-1651, 2008.
174. S. C. Zhang, X. Q. Zhang, F. W. Zhou, L. F. Yang, and X. J. Zhao, "Study of Qiankun capsule on mechanism of raising efficiency and reducing toxicity during chemotherapy in non-small cell lung cancer. Hebei Journal of Traditional ChineseMedicine, vol. 32, pp. 1448-1450, 2010.